Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Genetic Adaptation to Growth Under Laboratory Conditions in Escherichia coli and Salmonella enterica.

Knöppel A, Knopp M, Albrecht LM, Lundin E, Lustig U, Näsvall J, Andersson DI.

Front Microbiol. 2018 Apr 26;9:756. doi: 10.3389/fmicb.2018.00756. eCollection 2018.

2.

Selection of a multidrug resistance plasmid by sublethal levels of antibiotics and heavy metals.

Gullberg E, Albrecht LM, Karlsson C, Sandegren L, Andersson DI.

MBio. 2014 Oct 7;5(5):e01918-14. doi: 10.1128/mBio.01918-14.

3.

Strategies to decrease costs associated with GBS prophylaxis in preterm gestations.

Nguyen T, Guinn DA, Rodriguez A, Mehendale R, Quillen EQ, Albrecht LM.

Prim Care Update Ob Gyns. 1998 Jul 1;5(4):148-149.

PMID:
10838273
4.

A guide to references on drugs and breastfeeding.

Sandritter TL, Muniz OM, Albrecht LM.

J Hum Lact. 1997 Sep;13(3):239-42. Erratum in: J Hum Lact 1997 Dec;13(4):325.

PMID:
9341418
5.

Antidepressant use during breastfeeding.

Hatzopoulos FK, Albrecht LM.

J Hum Lact. 1996 Jun;12(2):139-41. Review.

PMID:
8932046
6.

Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.

Antimicrob Agents Chemother. 1991 Aug;35(8):1547-50.

7.

Vancomycin protein binding in patients with infections caused by Staphylococcus aureus.

Albrecht LM, Rybak MJ, Warbasse LH, Edwards DJ.

DICP. 1991 Jul-Aug;25(7-8):713-5.

PMID:
1949924
8.

Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis.

Rybak MJ, Lerner SA, Levine DP, Albrecht LM, McNeil PL, Thompson GA, Kenny MT, Yuh L.

Antimicrob Agents Chemother. 1991 Apr;35(4):696-700.

9.

Coagulase-negative staphylococci: incidence, pathogenicity, and treatment in the 1990s.

Bailey EM, Constance TD, Albrecht LM, Rybak MJ.

DICP. 1990 Jul-Aug;24(7-8):714-20. Review.

PMID:
2197813
10.

Vancomycin pharmacokinetics in burn patients and intravenous drug abusers.

Rybak MJ, Albrecht LM, Berman JR, Warbasse LH, Svensson CK.

Antimicrob Agents Chemother. 1990 May;34(5):792-5.

11.

Nephrotoxicity of vancomycin, alone and with an aminoglycoside.

Rybak MJ, Albrecht LM, Boike SC, Chandrasekar PH.

J Antimicrob Chemother. 1990 Apr;25(4):679-87.

PMID:
2351627
12.

Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.

Antimicrob Agents Chemother. 1990 Feb;34(2):257-60.

13.

Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.

Antimicrob Agents Chemother. 1989 Aug;33(8):1184-7.

14.

Single dose enoxacin for the treatment of uncomplicated urogenital gonorrhea.

Albrecht LM, Rybak MJ, Schubiner HH, Weiner LM.

Sex Transm Dis. 1989 Apr-Jun;16(2):114-7.

PMID:
2500718
15.

Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.

Antimicrob Agents Chemother. 1989 Apr;33(4):519-21.

16.

Comparison of serum sampling methods for determining vancomycin dosage regimens.

Albrecht LM, Rybak MJ, Boike SC, Pancorbo S.

Ther Drug Monit. 1988;10(1):85-90.

PMID:
3376187
17.

Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicin.

Rybak MJ, Frankowski JJ, Edwards DJ, Albrecht LM.

Antimicrob Agents Chemother. 1987 Oct;31(10):1461-4.

18.

Combination imipenem-aminoglycoside therapy.

Albrecht LM, Rybak MJ.

Drug Intell Clin Pharm. 1986 Jun;20(6):506. No abstract available.

PMID:
3459643

Supplemental Content

Loading ...
Support Center